Management of new oral anticoagulants in gastrointestinal bleeding and endoscopy

New oral direct anticoagulants agents are alternatives to warfarin for long-term anticoagulation in a growing number of patients that require long-term anticoagulation for atrial fibrillation, deep venous thrombosis and pulmonary embolism. These new agents with predictable pharmacokinetic and pharma...

Full description

Saved in:
Bibliographic Details
Published in:Gastroenterología y hepatología Vol. 38; no. 8; p. 501
Main Authors: del Molino, Fátima, Gonzalez, Isabel, Saperas, Esteve
Format: Journal Article
Language:Spanish
Published: Spain 01-10-2015
Subjects:
Online Access:Get more information
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:New oral direct anticoagulants agents are alternatives to warfarin for long-term anticoagulation in a growing number of patients that require long-term anticoagulation for atrial fibrillation, deep venous thrombosis and pulmonary embolism. These new agents with predictable pharmacokinetic and pharmacodynamics profiles offer a favorable global safety profile, but increased gastrointestinal bleeding compared to the vitamin K antagonists. Many gastroenterologists are unfamiliar and may be wary of these newer drugs, since Clinical experience is limited and no specific antidote is available to reverse their anticoagulant effect. In this article the risk of these new agents and, how to manage these agents in both the presence of acute gastrointestinal bleeding and in patients undergoing endoscopic procedures is reviewed.
ISSN:0210-5705
DOI:10.1016/j.gastrohep.2015.02.014